Obesity increases the risk for high-grade prostate cancer: Results from the REDUCE study

Cancer Epidemiology Biomarkers and Prevention

Volumn 23, Issue 12, 2014, Pages 2936-2942

  Vidal, Adriana C ^a   Howard, Lauren E ^a,b   Moreira, Daniel M ^c   Castro Santamaria, Ramiro ^d   Andriole, Gerald L ^e   Freedland, Stephen J ^a,b  

^a DUKE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b DURHAM VA MEDICAL CENTER   (United States)

^c DEPARTMENT OF UROLOGY   (United States)

^d GLAXOSMITHKLINE   (United States)

^e WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANDROSTANOLONE; DUTASTERIDE; PLACEBO; TESTOSTERONE;

ADULT; AGED; ALCOHOL CONSUMPTION; ARTICLE; BODY MASS; CANCER CHEMOTHERAPY; CANCER GRADING; CANCER GROWTH; CANCER RISK; CLINICAL FEATURE; COMORBIDITY; CONTROLLED STUDY; CORONARY ARTERY DISEASE; DIABETES MELLITUS; DISEASE ASSOCIATION; DOUBLE BLIND PROCEDURE; HUMAN; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; OBESITY; PROSTATE BIOPSY; PROSTATE CANCER; PROSTATE VOLUME; RACE DIFFERENCE; RANDOMIZED CONTROLLED TRIAL; RISK REDUCTION; SMOKING; TESTOSTERONE BLOOD LEVEL; TRANSRECTAL ULTRASONOGRAPHY; TUMOR BIOPSY; TUMOR VOLUME; CLINICAL TRIAL; COMPLICATION; MIDDLE AGED; PATHOLOGY; PROSTATIC NEOPLASMS; RISK FACTOR;

AGED; HUMANS; MALE; MIDDLE AGED; OBESITY; PROSTATIC NEOPLASMS; RISK FACTORS;

EID: 84919339803     PISSN: 10559965     EISSN: 15387755     Source Type: Journal    
DOI: 10.1158/1055-9965.EPI-14-0795     Document Type: Article

References (30)

1. Allott EH, Masko EM, Freedland SJ Obesity and prostate cancer: weighing the evidence. Eur Urol 2013; 63: 800-9.
2. Calle EE, Kaaks R. Overweight, obesity and cancer: epidemiological evidence and proposed mechanisms. Nat Rev Cancer 2004; 4: 579-91.
3. Center MM, Jemal A, Lortet-Tieulent J, Ward E., Ferlay J, Brawley O, et al International variation in prostate cancer incidence and mortality rates. Eur Urol 2012; 61: 1079-92.
4. Discacciati A, Orsini N, Wolk A. Body mass index and incidence of localized and advanced prostate cancer-a dose-response meta-analysis of prospective studies. Ann Oncol 2012; 23: 1665-71.
5. Banez LL, Hamilton RJ, Partin A.W., Vollmer RT, Sun L, Rodriguez C, et al Obesity-related plasma hemodilution and PSA concentration among men with prostate cancer. JAMA 2007; 298: 2275-80.
6. Barqawi AB, Golden BK, O'Donnell C, Brawer MK, Crawford ED Observed effect of age and body mass index on total and complexed PSA: analysis from a national screening program. Urology 2005; 65: 708-12.
7. Baillargeon J, Pollock BH, Kristal A.R., Bradshaw P., Hernandez J, Basler J, et al The association of body mass index and prostate-specific antigen in a population-based study. Cancer 2005; 103: 1092-5.
8. Gong Z, Neuhouser ML, Goodman P.J., Albanes D., Chi C, Hsing AW, et al Obesity, diabetes, and risk of prostate cancer: results from the prostate cancer prevention trial. Cancer Epidemiol Biomarkers Prev 2006; 15: 1977-83.
9. Andriole GL, Bostwick DG, Brawley O.W., Gomella LG, Marberger M, Montorsi F, et al Effect of dutasteride on the risk of prostate cancer. N Engl J Med 2010; 362: 1192-202.
10. Freedland SJ, Hamilton RJ, Gerber L, Banez L.L., Moreira DM, Andriole GL, et al. Statin use and risk of prostate cancer and high-grade prostate cancer: results from the REDUCE study. Prostate Cancer Prostatic Dis 2013; 16: 254-9.
11. Andersson SO, Wolk A, Bergstrom R., Adami HO, Engholm G, Englund A, et al Body size and prostate cancer: a 20-year follow-up study among 135006 Swedish construction workers. J Natl Cancer Inst 1997; 89: 385-9.
12. Baillargeon J, Platz EA, Rose D.P., Pollock BH, Ankerst DP, Haffner S, et al Obesity, adipokines, and prostate cancer in a prospective population-based study. Cancer Epidemiol Biomarkers Prev 2006; 15: 1331-5.
13. Bassett JK, Severi G, Baglietto L., MacInnis RJ, Hoang HN, Hopper JL, et al Weight change and prostate cancer incidence and mortality. Int J Cancer 2012; 131: 1711-9.
14. Burton A, Martin R, Galobardes B., Davey Smith G, Jeffreys M. Young adulthood body mass index and risk of cancer in later adulthood: historical cohort study. Cancer Causes Control 2010; 21: 2069-77.
15. Chamberlain C, Romundstad P, Vatten L., Gunnell D, Martin RM. The association of weight gain during adulthood with prostate cancer incidence and survival: a population-based cohort. Int J Cancer 2011; 129: 1199-206.
16. Engeland A, Tretli S, Bjorge T. Height, body mass index, and prostate cancer: a follow-up of 950000 Norwegian men. Br J Cancer 2003; 89: 1237-42.
17. Rodriguez C, Patel AV, Calle E.E., Jacobs EJ, Chao A, Thun MJ. Body mass index, height, and prostate cancer mortality in two large cohorts of adult men in the United States. Cancer Epidemiol Biomarkers Prev 2001; 10: 345-53.
18. Rodriguez C, Freedland SJ, Deka A, Jacobs E.J., McCullough ML, Patel AV, et al. Body mass index, weight change, and risk of prostate cancer in the Cancer Prevention Study II Nutrition Cohort. Cancer Epidemiol Biomarkers Prev 2007; 16: 63-9.
19. Snowdon DA, Phillips RL, Choi W. Diet, obesity, and risk of fatal prostate cancer. Am J Epidemiol 1984; 120: 244-50.
20. Haggstrom C, Stocks T, Ulmert D., Bjorge T, Ulmer H, Hallmans G., et al. Prospective study on metabolic factors and risk of prostate cancer. Cancer 2012; 118: 6199-206.
21. Porter MP, Stanford JL Obesity and the risk of prostate cancer. Prostate 2005; 62: 316-21.
22. Wright ME, Chang SC, Schatzkin A, Albanes D., Kipnis V, Mouw T, et al Prospective study of adiposity and weight change in relation to prostate cancer incidence and mortality. Cancer 2007; 109: 675-84.
23. Stocks T, Hergens MP, Englund A, Ye W., Stattin P. Blood pressure, body size and prostate cancer risk in the Swedish Construction Workers cohort. Int J Cancer 2010; 127: 1660-8.
24. Macinnis RJ, English DR Body size and composition and prostate cancer risk: systematic review and meta-regression analysis. Cancer Causes Control 2006; 17: 989-1003.
25. Mistry T, Digby JE, Desai K.M., Randeva HS. Obesity and prostate cancer: a role for adipokines. Eur Urol 2007; 52: 46-53.
26. Schnoeller T, Jentzmik F, Rinnab L., Cronauer MV, Damjanoski I, Zengerling F, et al Circulating free testosterone is an independent predictor of advanced disease in patients with clinically localized prostate cancer. World J Urol 2013; 31: 253-9.
27. Hsing AW, Sakoda LC, Chua S Jr. Obesity, metabolic syndrome, and prostate cancer. Am J Clin Nutr 2007; 86:s843-57.
28. Freedland SJ, Terris MK, Platz E.A., Presti JC Jr. Body mass index as a predictor of prostate cancer: development versus detection on biopsy. Urology 2005; 66: 108-13.
29. Turley RS, Hamilton RJ, Terris M.K., Kane CJ, Aronson WJ, Presti JC Jr, et al. Small transrectal ultrasound volume predicts clinically significant Gleason score upgrading after radical prostatectomy: results from the SEARCH database. J Urol. 2008; 179: 523-7.
30. Muller RL, Gerber L, Moreira D.M., Andriole G Jr, Hamilton RJ, Fleshner N, et al. Obesity is associated with increased prostate growth and attenuated prostate volume reduction by dutasteride. Eur Urol 2013; 63:1115-21.